메뉴 건너뛰기




Volumn 78, Issue 6, 2014, Pages 1334-1342

Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects

Author keywords

Cathepsin S inhibitor; LY3000328

Indexed keywords

BENZOPYRAN DERIVATIVE; CARBAMIC ACID DERIVATIVE; CATHEPSIN; CATHEPSIN S; LY3000328; PROTEINASE INHIBITOR;

EID: 84918775242     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12470     Document Type: Article
Times cited : (24)

References (23)
  • 1
    • 79960062100 scopus 로고    scopus 로고
    • The emerging relevance of the cysteine protease Cathepsin S in disease
    • Small DM, Burden RE, Scott CJ. The emerging relevance of the cysteine protease Cathepsin S in disease. Clinic Rev Bone Miner Metab 2011; 9: 122-32.
    • (2011) Clinic Rev Bone Miner Metab , vol.9 , pp. 122-132
    • Small, D.M.1    Burden, R.E.2    Scott, C.J.3
  • 2
    • 79960073695 scopus 로고    scopus 로고
    • Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm
    • Sjoberg S, Shi GP. Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm. Clinic Rev Bone Miner Metab 2011; 9: 138-47.
    • (2011) Clinic Rev Bone Miner Metab , vol.9 , pp. 138-147
    • Sjoberg, S.1    Shi, G.P.2
  • 4
    • 34447636403 scopus 로고    scopus 로고
    • Do cathepsins play a role in abdominal aortic aneurysm pathogenesis
    • Sukhova GK, Shi GP. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci 2006; 1085: 161-9.
    • (2006) Ann N y Acad Sci , vol.1085 , pp. 161-169
    • Sukhova, G.K.1    Shi, G.P.2
  • 6
    • 0032145836 scopus 로고    scopus 로고
    • Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
    • Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-83.
    • (1998) J Clin Invest , vol.102 , pp. 576-583
    • Sukhova, G.K.1    Shi, G.P.2    Simon, D.I.3    Chapman, H.A.4    Libby, P.5
  • 8
    • 0036735233 scopus 로고    scopus 로고
    • Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice
    • Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, Eriksson P. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002; 161: 939-45.
    • (2002) Am J Pathol , vol.161 , pp. 939-945
    • Jormsjö, S.1    Wuttge, D.M.2    Sirsjö, A.3    Whatling, C.4    Hamsten, A.5    Stemme, S.6    Eriksson, P.7
  • 9
    • 84869444979 scopus 로고    scopus 로고
    • Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
    • Qin Y, Cao X, Guo J, Zhang Y, Pan L, Zhang H, Li H, Tang C, Du J, Shi G. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovasc Res 2012; 96: 401-10.
    • (2012) Cardiovasc Res , vol.96 , pp. 401-410
    • Qin, Y.1    Cao, X.2    Guo, J.3    Zhang, Y.4    Pan, L.5    Zhang, H.6    Li, H.7    Tang, C.8    Du, J.9    Shi, G.10
  • 11
    • 79960150092 scopus 로고    scopus 로고
    • Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases
    • Qin Y, Shi GP. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol Ther 2011; 131: 338-50.
    • (2011) Pharmacol Ther , vol.131 , pp. 338-350
    • Qin, Y.1    Shi, G.P.2
  • 14
    • 84864259637 scopus 로고    scopus 로고
    • Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: A randomized population-based study
    • Lv BJ, Lindholt JS, Cheng X, Wang J, Shi GP. Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study. PLoS ONE 2012; 7: e41813.
    • (2012) PLoS ONE , vol.7 , pp. e41813
    • Lv, B.J.1    Lindholt, J.S.2    Cheng, X.3    Wang, J.4    Shi, G.P.5
  • 15
    • 84860221877 scopus 로고    scopus 로고
    • Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease
    • Smith ER, Tomlinson LA, Ford ML, McMahon LP, Rajkumar C, Holt SG. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 2012; 59: 973-8.
    • (2012) Hypertension , vol.59 , pp. 973-978
    • Smith, E.R.1    Tomlinson, L.A.2    Ford, M.L.3    Mc Mahon, L.P.4    Rajkumar, C.5    Holt, S.G.6
  • 16
    • 0025940824 scopus 로고
    • Tight-binding inhibition of cathepsin S by cystatins
    • Brömme D, Rinne R, Kirschke H. Tight-binding inhibition of cathepsin S by cystatins. Biomed Biochim Acta 1991; 50: 631-5.
    • (1991) Biomed Biochim Acta , vol.50 , pp. 631-635
    • Brömme, D.1    Rinne, R.2    Kirschke, H.3
  • 18
    • 4143146210 scopus 로고    scopus 로고
    • Important role of cathepsin S in generating peptides for TAP-independent MHC class i crosspresentation in vivo
    • Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004; 21: 155-65.
    • (2004) Immunity , vol.21 , pp. 155-165
    • Shen, L.1    Sigal, L.J.2    Boes, M.3    Rock, K.L.4
  • 19
    • 0030614844 scopus 로고    scopus 로고
    • Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH
    • Charman WL, Porter CJH, Mithani A, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269-82.
    • (1997) J Pharm Sci , vol.86 , pp. 269-282
    • Charman, W.L.1    Porter, C.J.H.2    Mithani, A.3    Dressman, J.B.4
  • 20
  • 21
    • 0033380873 scopus 로고    scopus 로고
    • Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig
    • Conde K, Roy S, Freake HC, Newton RS, Fernandez ML. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig. Lipids 1999; 34: 1327-32.
    • (1999) Lipids , vol.34 , pp. 1327-1332
    • Conde, K.1    Roy, S.2    Freake, H.C.3    Newton, R.S.4    Fernandez, M.L.5
  • 22
    • 70349462959 scopus 로고    scopus 로고
    • Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects
    • Wolk R, Chen D, Clark RW, Mancuso J, Barclay PL. Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects. Clin Pharmacol Ther 2009; 86: 430-7.
    • (2009) Clin Pharmacol Ther , vol.86 , pp. 430-437
    • Wolk, R.1    Chen, D.2    Clark, R.W.3    Mancuso, J.4    Barclay, P.L.5
  • 23
    • 0034093374 scopus 로고    scopus 로고
    • Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: The concept of cholesterol buffering capacity
    • Ness GC, Chambers CM. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc Soc Exp Biol Med 2000; 224: 8-19.
    • (2000) Proc Soc Exp Biol Med , vol.224 , pp. 8-19
    • Ness, G.C.1    Chambers, C.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.